Drug
Cidofovir Anhydrous
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Drug Resistance | 150 | 87.7 | 98.0 | signal |
| 2 | Nephropathy Toxic | 65 | 87.6 | 91.8 | signal |
| 3 | Cytomegalovirus Infection | 89 | 80.3 | 85.6 | signal |
| 4 | Thrombotic Microangiopathy | 25 | 38.6 | 39.3 | signal |
| 5 | Bacteraemia | 29 | 36.9 | 37.6 | signal |
| 6 | Multiple Organ Dysfunction Syndrome | 68 | 36.5 | 38.3 | signal |
| 7 | Drug Ineffective For Unapproved Indication | 79 | 21.2 | 22.4 | signal |
| 8 | Posterior Reversible Encephalopathy Syndrome | 13 | 20.4 | 20.6 | signal |
| 9 | Nephropathy | 12 | 19.1 | 19.3 | signal |
| 10 | Lymphopenia | 17 | 18.1 | 18.3 | signal |
| 11 | Pneumocystis Jirovecii Pneumonia | 12 | 17.9 | 18.1 | signal |
| 12 | Mucosal Inflammation | 31 | 17.8 | 18.1 | signal |
| 13 | Renal Impairment | 95 | 17.0 | 18.1 | signal |
| 14 | Uveitis | 14 | 15.5 | 15.6 | signal |
| 15 | Acute Hepatic Failure | 14 | 15.4 | 15.5 | signal |
| 16 | Metabolic Acidosis | 30 | 14.2 | 14.4 | signal |
| 17 | Acute Kidney Injury | 140 | 13.7 | 15.1 | signal |
| 18 | Haematuria | 31 | 13.5 | 13.8 | signal |
| 19 | Electrolyte Imbalance | 10 | 13.0 | 13.1 | signal |
| 20 | Encephalopathy | 21 | 12.8 | 13.0 | signal |
| 21 | Cytopenia | 10 | 12.5 | 12.6 | signal |
| 22 | Skin Lesion | 22 | 12.1 | 12.2 | signal |
| 23 | Pancytopenia | 44 | 11.8 | 12.1 | signal |
| 24 | Coagulopathy | 12 | 10.8 | 10.9 | signal |
| 25 | Hemiparesis | 12 | 10.5 | 10.6 | signal |
| 26 | Oral Herpes | 13 | 10.0 | 10.1 | signal |
| 27 | Hepatic Failure | 20 | 9.9 | 10.0 | signal |
| 28 | Respiratory Failure | 46 | 9.4 | 9.7 | signal |
| 29 | Pancreatitis Acute | 14 | 9.4 | 9.5 | signal |
| 30 | Septic Shock | 25 | 8.6 | 8.8 | signal |
| 31 | Multi-organ Failure | 10 | 8.5 | 8.6 | signal |
| 32 | Pharyngitis | 7 | 8.4 | 8.4 | signal |
| 33 | Pneumonitis | 15 | 8.3 | 8.4 | signal |
| 34 | Hepatitis | 14 | 8.2 | 8.2 | signal |
| 35 | Candida Infection | 9 | 8.1 | 8.1 | signal |
| 36 | Ataxia | 6 | 7.5 | 7.5 | signal |
| 37 | Proteinuria | 9 | 7.1 | 7.2 | signal |
| 38 | Myelosuppression | 16 | 7.0 | 7.1 | signal |
| 39 | Febrile Neutropenia | 31 | 7.0 | 7.1 | signal |
| 40 | Tuberculosis | 6 | 7.0 | 7.0 | signal |
| 41 | Therapy Partial Responder | 7 | 6.9 | 7.0 | signal |
| 42 | Treatment Failure | 35 | 6.4 | 6.5 | signal |
| 43 | Nervous System Disorder | 13 | 6.2 | 6.2 | signal |
| 44 | Fluid Overload | 6 | 6.1 | 6.1 | signal |
| 45 | Bone Marrow Failure | 8 | 5.8 | 5.9 | signal |
| 46 | Hepatic Function Abnormal | 14 | 5.6 | 5.7 | signal |
| 47 | Gastrointestinal Haemorrhage | 31 | 5.5 | 5.6 | signal |
| 48 | Vasculitis | 4 | 5.1 | 5.1 | signal |
| 49 | Diarrhoea Haemorrhagic | 3 | 4.8 | 4.8 | signal |
| 50 | Leukaemia | 3 | 4.7 | 4.8 | signal |
| 51 | Product Prescribing Issue | 6 | 4.4 | 4.4 | signal |
| 52 | Status Epilepticus | 3 | 4.0 | 4.0 | signal |
| 53 | Metastases To Lung | 3 | 3.9 | 3.9 | no signal |
| 54 | Lymphoma | 4 | 3.9 | 3.9 | signal |
| 55 | Acute Myeloid Leukaemia | 4 | 3.8 | 3.8 | signal |